What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Antibody
Arthur A. Vandenbark mainly investigates Immunology, Experimental autoimmune encephalomyelitis, T cell, Immune system and T-cell receptor.
His study in Adoptive cell transfer, Antigen, IL-2 receptor, FOXP3 and Interleukin 10 falls under the purview of Immunology.
Arthur A. Vandenbark has included themes like Encephalomyelitis and Pharmacology in his Experimental autoimmune encephalomyelitis study.
His research integrates issues of Myelin, T lymphocyte and Major histocompatibility complex in his study of T cell.
His Immune system research includes elements of Cytokine, Etiology, Pathology, Brain ischemia and Lymphocyte.
Arthur A. Vandenbark interconnects Molecular biology, Myelin basic protein, Peptide and Immunotherapy in the investigation of issues within T-cell receptor.
His most cited work include:
- Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains (308 citations)
- Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains (308 citations)
- T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. (286 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Immunology, Experimental autoimmune encephalomyelitis, T cell, T-cell receptor and Antigen.
As part of his studies on Immunology, Arthur A. Vandenbark often connects relevant areas like Myelin basic protein.
His Experimental autoimmune encephalomyelitis research includes themes of Myelin and FOXP3.
The concepts of his T cell study are interwoven with issues in Cell culture, T lymphocyte, Molecular biology, Cell biology and Epitope.
His research investigates the connection between T-cell receptor and topics such as IL-2 receptor that intersect with problems in Natural killer T cell.
In his research, Peptide vaccine is intimately related to Vaccination, which falls under the overarching field of Antigen.
He most often published in these fields:
- Immunology (83.09%)
- Experimental autoimmune encephalomyelitis (50.37%)
- T cell (37.87%)
What were the highlights of his more recent work (between 2011-2021)?
- Immunology (83.09%)
- Experimental autoimmune encephalomyelitis (50.37%)
- CD74 (6.25%)
In recent papers he was focusing on the following fields of study:
Arthur A. Vandenbark spends much of his time researching Immunology, Experimental autoimmune encephalomyelitis, CD74, MHC class II and Immune system.
Multiple sclerosis, Regulatory B cells, Inflammation, Microglia and Myelin oligodendrocyte glycoprotein are among the areas of Immunology where the researcher is concentrating his efforts.
His research in Inflammation intersects with topics in Stroke, Central nervous system and Pathology.
His Experimental autoimmune encephalomyelitis study combines topics from a wide range of disciplines, such as B cell, Regulatory T cell, Encephalomyelitis, FOXP3 and Interleukin 10.
His Immune system study integrates concerns from other disciplines, such as Cytokine and Depression.
His T cell research integrates issues from Neuroscience and Virology.
Between 2011 and 2021, his most popular works were:
- The HLA-DRB1*15:01-restricted goodpasture's T cell epitope induces GN (48 citations)
- MIF and D-DT are potential disease severity modifiers in male MS subjects (46 citations)
- Intrastriatal B-cell administration limits infarct size after stroke in B-cell deficient mice (46 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Antibody
Arthur A. Vandenbark mostly deals with Immunology, Experimental autoimmune encephalomyelitis, Receptor, Pharmacology and Myelin oligodendrocyte glycoprotein.
Arthur A. Vandenbark combines subjects such as Stroke and Endocrinology with his study of Immunology.
His Experimental autoimmune encephalomyelitis study is related to the wider topic of Multiple sclerosis.
His study explores the link between Receptor and topics such as Proinflammatory cytokine that cross with problems in Pathogenesis.
As part of one scientific family, Arthur A. Vandenbark deals mainly with the area of Pharmacology, narrowing it down to issues related to the Ischemia, and often Anesthesia, Cerebral infarction and Cerebral cortex.
The study incorporates disciplines such as Estrogen and FOXP3 in addition to Regulatory B cells.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
